| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.54 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.38 | 0.04 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.35 | 0.06 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.22 | 0.2 |